Earnings Summary for Trevi Therapeutics Inc
Intellectia.AI Updated: 1970-01-01
Earnings Summary for Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. (TREVI) recently reported its financial results for the quarterly period ended June 30, 2024.
Key Financial Metrics
| Metric | Current Quarter (Q2 2024) | Previous Quarter (Q1 2024) | Year-Over-Year (Q2 2023) | Consensus Estimates (Current Quarter) |
|---|---|---|---|---|
| Earnings Per Share (EPS) | -$0.10 | -$0.12 | -$0.12 | -$0.11 |
Interpretation: Trevi Therapeutics, Inc. reported an EPS of -$0.10 for Q2 2024, showing an improvement compared to the previous quarter's EPS of -$0.12 and the year-over-year EPS of -$0.12. The actual EPS was better than the consensus estimate of -$0.11.
Stock Price Movement
Following the earnings release, Trevi Therapeutics, Inc.’s stock price saw an after-event percentage change of 8.11%.
Conclusion: Trevi Therapeutics, Inc. showed a slight improvement in EPS compared to the previous quarter and year-over-year, with the actual EPS surpassing the consensus estimate. The stock responded positively with an 8.11% increase following the earnings release. Other key segments, operational data, officer comments, dividend announcements, and forward guidance were not provided in the earnings report.
